Your browser doesn't support javascript.
loading
Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance.
Clay-Gilmour, Alyssa I; Hildebrandt, Michelle A T; Brown, Elizabeth E; Hofmann, Jonathan N; Spinelli, John J; Giles, Graham G; Cozen, Wendy; Bhatti, Parveen; Wu, Xifeng; Waller, Rosalie G; Belachew, Alem A; Robinson, Dennis P; Norman, Aaron D; Sinnwell, Jason P; Berndt, Sonja I; Rajkumar, S Vincent; Kumar, Shaji K; Chanock, Stephen J; Machiela, Mitchell J; Milne, Roger L; Slager, Susan L; Camp, Nicola J; Ziv, Elad; Vachon, Celine M.
Affiliation
  • Clay-Gilmour AI; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
  • Hildebrandt MAT; Department of Biostatistics and Epidemiology, Arnold School of Public Health, University of South Carolina, Greenville, SC.
  • Brown EE; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Hofmann JN; Department of Pathology, School of Medicine at the; University of Alabama, Birmingham, AL.
  • Spinelli JJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, MD.
  • Giles GG; Division of Population Oncology, BC Cancer, BC, Canada.
  • Cozen W; School of Population and Public Health, University of British Columbia, BC, Canada.
  • Bhatti P; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.
  • Wu X; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
  • Waller RG; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Belachew AA; Department of Preventive Medicine, Keck School of Medicine at University of Southern California, Los Angeles, CA.
  • Robinson DP; Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Norman AD; Cancer Control Research, BC Cancer, Vancouver, BC, Canada.
  • Sinnwell JP; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Berndt SI; Division of Hematology and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Rajkumar SV; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kumar SK; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, and.
  • Chanock SJ; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
  • Machiela MJ; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, and.
  • Milne RL; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, and.
  • Slager SL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, MD.
  • Camp NJ; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN; and.
  • Ziv E; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN; and.
  • Vachon CM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, MD.
Blood Adv ; 4(12): 2789-2797, 2020 06 23.
Article de En | MEDLINE | ID: mdl-32569378
ABSTRACT
So far, 23 germline susceptibility loci have been associated with multiple myeloma (MM) risk. It is unclear whether the genetic variation associated with MM susceptibility also predisposes to its precursor, monoclonal gammopathy of undetermined significance (MGUS). Leveraging 2434 MM cases, 754 MGUS cases, and 2 independent sets of controls (2567/879), we investigated potential shared genetic susceptibility of MM and MGUS by (1) performing MM and MGUS genome-wide association studies (GWAS); (2) validating the association of a polygenic risk score (PRS) based on 23 established MM loci (MM-PRS) with risk of MM, and for the first time with MGUS; and (3) examining genetic correlation of MM and MGUS. Heritability and genetic estimates yielded 17% (standard error [SE] ±0.04) and 15% (SE ±0.11) for MM and MGUS risk, respectively, and a 55% (SE ±0.30) genetic correlation. The MM-PRS was associated with risk of MM when assessed continuously (odds ratio [OR], 1.17 per SD; 95% confidence interval [CI], 1.13-1.21) or categorically (OR, 1.70; 95% CI, 1.38-2.09 for highest; OR, 0.71; 95% CI, 0.55-0.90 for lowest compared with middle quintile). The MM-PRS was similarly associated with MGUS (OR, 1.19 per SD; 95% CI, 1.14-1.26 as a continuous measure, OR, 1.77, 95%CI 1.29-2.43 for highest and OR, 0.70, 95%CI 0.50-0.98 for lowest compared with middle quintile). MM and MGUS associations did not differ by age, sex, or MM immunoglobulin isotype. We validated a 23-SNP MM-PRS in an independent series of MM cases and provide evidence for its association with MGUS. Our results suggest shared common genetic susceptibility to MM and MGUS.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Gammapathie monoclonale de signification indéterminée / Myélome multiple Type d'étude: Etiology_studies Limites: Humans Langue: En Journal: Blood Adv Année: 2020 Type de document: Article Pays d'affiliation: Mongolie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Gammapathie monoclonale de signification indéterminée / Myélome multiple Type d'étude: Etiology_studies Limites: Humans Langue: En Journal: Blood Adv Année: 2020 Type de document: Article Pays d'affiliation: Mongolie